Helicobacter pylori and functional dyspepsia: An unsolved issue?

World Journal of Gastroenterology

Volumn , Issue 27, 2014, Pages 8957-8963

  Zullo, Angelo ^a   Hassan, Cesare ^a   De Francesco, Vincenzo ^b   Repici, Alessandro ^c   Manta, Raffaele ^d   Tomao, Silverio ^e,f   Annibale, Bruno ^g   Vaira, Dino ^h  

^a NUOVO REGINA MARGHERITA HOSPITAL   (Italy)

^b Riuniti Hospital   (Italy)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^d Nuovo Ospedale S Agostino   (Italy)

^e SANTA MARIA GORETTI HOSPITAL   (Italy)

^f SAPIENZA UNIVERSITY OF ROME   (Italy)

^g SAPIENZA UNIVERSITY OF ROME   (Italy)

^h UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Dyspepsia; Helicobacter pylori; Pathogenesis; Symptoms; Therapy

Indexed keywords

ACETYLSALICYLIC ACID; PLACEBO; ANTIINFECTIVE AGENT;

BACTERIAL CLEARANCE; CLINICAL ASSESSMENT; CLINICAL TRIAL (TOPIC); DRUG USE; DYSPEPSIA; EPIGASTRIC FULLNESS; EPIGASTRIC PAIN; HELICOBACTER INFECTION; HUMAN; META ANALYSIS (TOPIC); PATHOGENESIS; PEPTIC ULCER; REVIEW; SYMPTOM; COMPLICATION; DRUG EFFECTS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; MICROBIOLOGY; PATHOGENICITY; RISK FACTOR; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; DYSPEPSIA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; RISK FACTORS; TREATMENT OUTCOME;

EID: 84905368057     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i27.8957     Document Type: Review

References (47)

1. Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GN. Functional gastroduodenal disorders. Gut 1999; 45 Suppl 2: II37-II42 [PMID: 10457043 DOI: 10.1136/gut.45.2008.ii37]
2. Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, Malagelada JR, Stanghellini V. Functional gastroduodenal disorders. Gastroenterology 2006; 130: 1466-1479 [PMID: 16678560 DOI: 10.1053/j.gastro.2005.11.059]
3. Moayyedi P, Deeks J, Talley NJ, Delaney B, Forman D. An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviews. Am J Gastroenterol 2003; 98: 2621-2626 [PMID: 14687807 DOI: 10.1111/j.1572-0241.2003.08724.x]
4. Moayyedi P, Soo S, Deeks J, Delaney B, Harris A, Innes M, Oakes R, Wilson S, Roalfe A, Bennett C, Forman D. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev 2005; 2: CD002096 [PMID: 15674892 DOI: 10.1002/14651858.CD002096.pub5]
5. Tack J, Piessevaux H, Coulie B, Caenepeel P, Janssens J. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 1998; 115: 1346-1352 [PMID: 9834261 DOI: 10.1016/S0016-5085(98)70012-5]
6. Sarnelli G, Cuomo R, Janssens J, Tack J. Symptom patterns and pathophysiological mechanisms in dyspeptic patients with and without Helicobacter pylori. Dig Dis Sci 2003; 48: 2229-2236 [PMID: 14714606 DOI: 10.1023/B:DDAS.0000007856.71462.6c]
7. Talley NJ, Xia HH. Helicobacter pylori infection and non-ulcer dyspepsia. Br Med Bull 1998; 54: 63-69 [PMID: 9604431 DOI: 10.1093/oxfordjournals.bmb.a011680]
8. el-Omar EM, Penman ID, Ardill JE, Chittajallu RS, Howie C, McColl KE. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology 1995; 109: 681-691 [PMID: 7657096 DOI: 10.1016/0016-5085(95)90374-7]
9. el-Omar E, Penman I, Ardill JE, McColl KE. A substantial proportion of non-ulcer dyspepsia patients have the same abnormality of acid secretion as duodenal ulcer patients. Gut 1995; 36: 534-538 [PMID: 7737559 DOI: 10.1136/gut.36.4.534]
10. Suzuki H, Moayyedi P. Helicobacter pylori infection in functional dyspepsia. Nat Rev Gastroenterol Hepatol 2013; 10: 168-174 [PMID: 23358394 DOI: 10.1038/nrgastro.2013.9]
11. McColl K, Murray L, El-Omar E, Dickson A, El-Nujumi A, Wirz A, Kelman A, Penny C, Knill-Jones R, Hilditch T. Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. N Engl J Med 1998; 339: 1869-1874 [PMID: 9862941 DOI: 10.1056/NEJM199812243392601]
12. Tahara T, Shibata T, Yamashita H, Hirata I, Arisawa T. The Role of RANTES Promoter Polymorphism in Functional Dyspepsia. J Clin Biochem Nutr 2009; 45: 235-240 [PMID: 19794934 DOI: 10.3164/jcbn.09-31]
13. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 1161-1181 [PMID: 8827022 DOI: 10.1097/00000478-199610000-00001]
14. Fock KM. Functional dyspepsia, H. pylori and post infectious FD. J Gastroenterol Hepatol 2011; 26 Suppl 3: 39-41 [PMID: 21443707 DOI: 10.1111/j.1440-1746.2011.06649.x]
15. Li XB, Chen HM, Lu H, Zheng Q, Chen XY, Peng YS, Ge ZZ, Liu WZ. Role of Helicobacter pylori infection on neuronal expression in the stomach and spinal cord of a murine model. J Dig Dis 2009; 10: 286-292 [PMID: 19906107 DOI: 10.1111/j.1751-2980.2009.00397.x]
16. Talley NJ, Vakil N, Ballard ED, Fennerty MB. Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia. N Engl J Med 1999; 341: 1106-1111 [PMID: 10511608 DOI: 10.1056/NEJM199910073411502]
17. Tack J, Demedts I, Dehondt G, Caenepeel P, Fischler B, Zandecki M, Janssens J. Clinical and pathophysiological characteristics of acute-onset functional dyspepsia. Gastroenterology 2002; 122: 1738-1747 [PMID: 12055579 DOI: 10.1053/gast.2002.33663]
18. Mearin F, Pérez-Oliveras M, Perelló A, Vinyet J, Ibañez A, Coderch J, Perona M. Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study. Gastroenterology 2005; 129: 98-104 [PMID: 16012939 DOI: 10.1053/j.gastro.2005.04.012]
19. Zanini B, Ricci C, Bandera F, Caselani F, Magni A, Laronga AM, Lanzini A. Incidence of post-infectious irritable bowel syndrome and functional intestinal disorders following a water-borne viral gastroenteritis outbreak. Am J Gastroenterol 2012; 107: 891-899 [PMID: 22525306 DOI: 10.1038/ajg.2012.102]
20. Li X, Chen H, Lu H, Li W, Chen X, Peng Y, Ge Z. The study on the role of inflammatory cells and mediators in post-infectious functional dyspepsia. Scand J Gastroenterol 2010; 45: 573-581 [PMID: 20163288 DOI: 10.3109/00365521003632576]
21. Futagami S, Shindo T, Kawagoe T, Horie A, Shimpuku M, Gudis K, Iwakiri K, Itoh T, Sakamoto C. Migration of eosinophils and CCR2-/CD68-double positive cells into the duodenal mucosa of patients with postinfectious functional dyspepsia. Am J Gastroenterol 2010; 105: 1835-1842 [PMID: 20461070 DOI: 10.1038/ajg.2010.151]
22. Zhao B, Zhao J, Cheng WF, Shi WJ, Liu W, Pan XL, Zhang GX. Efficacy of Helicobacter pylori eradication therapy on functional dyspepsia: a meta-analysis of randomized controlled studies with 12-month follow-up. J Clin Gastroenterol 2014; 48: 241-247 [PMID: 24002127 DOI: 10.1097/MCG.0b013e31829f2e25]
23. Bruley Des Varannes S, Fléjou JF, Colin R, Zaïm M, Meunier A, Bidaut-Mazel C. There are some benefits for eradicating Helicobacter pylori in patients with non-ulcer dyspepsia. Aliment Pharmacol Ther 2001; 15: 1177-1185 [PMID: 11472320 DOI: 10.1046/j.1365-2036.2001.01014.x]
24. Hsu PI, Lai KH, Tseng HH, Lo GH, Lo CC, Lin CK, Cheng JS, Chan HH, Ku MK, Peng NJ, Chien EJ, Chen W, Hsu PN. Eradication of Helicobacter pylori prevents ulcer development in patients with ulcer-like functional dyspepsia. Aliment Pharmacol Ther 2001; 15: 195-201 [PMID: 11148437 DOI: 10.1046/j.1365-2036.2001.00903.x]
25. Talley NJ, Janssens J, Lauritsen K, Rácz I, Bolling-Sternevald E. Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group. BMJ 1999; 318: 833-837 [PMID: 10092259 DOI: 10.1136/bmj.318.7187.833]
26. Koelz HR, Arnold R, Stolte M, Fischer M, Blum AL. Treatment of Helicobacter pylori in functional dyspepsia resistant to conventional management: a double blind randomised trial with a six month follow up. Gut 2003; 52: 40-46 [PMID: 12477757 DOI: 10.1136/gut.52.1.40]
27. Koskenpato J, Farkkilä M, Sipponen P. Helicobacter pylori eradication and standardized 3-month omeprazole therapy in functional dyspepsia. Am J Gastroenterol 2001; 96: 2866-2872 [PMID: 11693319 DOI: 10.1111/j.1572-0241.2001.04240.x]
28. Mazzoleni LE, Sander GB, Francesconi CF, Mazzoleni F, Uchoa DM, De Bona LR, Milbradt TC, Von Reisswitz PS, Berwanger O, Bressel M, Edelweiss MI, Marini SS, Molina CG, Folador L, Lunkes RP, Heck R, Birkhan OA, Spindler BM, Katz N, Colombo Bda S, Guerrieri PP, Renck LB, Grando E, Hocevar de Moura B, Dahmer FD, Rauber J, Prolla JC. Helicobacter pylori eradication in functional dyspepsia: HEROES trial. Arch Intern Med 2011; 171: 1929-1936 [PMID: 22123802 DOI: 10.1001/archinternmed.2011.533]
29. Veldhuyzen van Zanten S, Fedorak RN, Lambert J, Cohen L, Vanjaka A. Absence of symptomatic benefit of lansoprazole, clarithromycin, and amoxicillin triple therapy in eradication of Helicobacter pylori positive, functional (nonulcer) dyspepsia. Am J Gastroenterol 2003; 98: 1963-1969 [PMID: 14499772 DOI: 10.1016/S0002-9270(03)00432-5]
30. Gilvarry J, Buckley MJ, Beattie S, Hamilton H, O'Morain CA. Eradication of Helicobacter pylori affects symptoms in non-ulcer dyspepsia. Scand J Gastroenterol 1997; 32: 535-540 [PMID: 9200283]
31. Sodhi JS, Javid G, Zargar SA, Tufail S, Shah A, Khan BA, Yattoo GN, Gulzar GM, Khan MA, Lone MI, Saif Ru, Parveen S, Shoukat A. Prevalence of Helicobacter pylori infection and the effect of its eradication on symptoms of functional dyspepsia in Kashmir, India. J Gastroenterol Hepatol 2013; 28: 808-813 [PMID: 23432600 DOI: 10.1111/jgh.12178]
32. Blum AL, Talley NJ, O'Moráin C, van Zanten SV, Labenz J, Stolte M, Louw JA, Stubberöd A, Theodórs A, Sundin M, Bolling-Sternevald E, Junghard O. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group. N Engl J Med 1998; 339: 1875-1881 [PMID: 9862942 DOI: 10.1056/NEJM199812243392602]
33. Cover TL, Blaser MJ. Helicobacter pylori in health and disease. Gastroenterology 2009; 136: 1863-1873 [PMID: 19457415 DOI: 10.1053/j.gastro.2009.01.073]
34. Camilleri M, Stanghellini V. Current management strategies and emerging treatments for functional dyspepsia. Nat Rev Gastroenterol Hepatol 2013; 10: 187-194 [PMID: 23381190 DOI: 10.1038/nrgastro.2013.11]
35. Keohane J, Quigley EM. Functional dyspepsia: the role of visceral hypersensitivity in its pathogenesis. World J Gastroenterol 2006; 12: 2672-2676 [PMID: 16718751 DOI: 10.3748/wjg.v12.i17.2672]
36. Brandt LJ, Chey WD, Foxx-Orenstein AE, Schiller LR, Schoenfeld PS, Spiegel BM, Talley NJ, Quigley EM. An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol 2009; 104 Suppl 1: S1-35 [PMID: 19521341 DOI: 10.1038/ajg.2008.122]
37. Laine L. Review article: gastrointestinal bleeding with low-dose aspirin - what's the risk? Aliment Pharmacol Ther 2006; 24: 897-908 [PMID: 16948802 DOI: 10.1111/j.1365-2036.2006.03077.x]
38. Sanchez-Mete L, Zullo A, Hassan C, Rinaldi V, Magno MS, Festuccia F, Morini S, Attili AF. Helicobacter pylori diagnosis in patients with liver cirrhosis. Dig Liver Dis 2003; 35: 566-570 [PMID: 14567461 DOI: 10.1016/S1590-8658(03)00029-X]
39. Hong SJ, Sung IK, Kim JG, Lee SW, Choi SC, Yang CH, Lee SI, Lee DH, Kim GH, Jeon SW, Park MI, Park SK, Park BJ, Seol SY. Failure of a Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of H. pylori Eradication in H. pylori-Infected Patients with Functional Dyspepsia. Gut Liver 2011; 5: 468-471 [PMID: 22195245 DOI: 10.5009/gnl.2011.5.4.468]
40. Feinle-Bisset C, Azpiroz F. Dietary and lifestyle factors in functional dyspepsia. Nat Rev Gastroenterol Hepatol 2013; 10: 150-157 [PMID: 23296252 DOI: 10.1038/nrgastro.2012.246]
41. Zullo A, Hassan C, Repici A, Bruzzese V. Helicobacter pylori eradication and reflux disease onset: did gastric acid get "crazy"? World J Gastroenterol 2013; 19: 786-789 [PMID: 23429673 DOI: 10.3748/wjg.v19.i6.786]
42. Noh YW, Jung HK, Kim SE, Jung SA. Overlap of Erosive and Non-erosive Reflux Diseases With Functional Gastrointestinal Disorders According to Rome III Criteria. J Neurogastroenterol Motil 2010; 16: 148-156 [PMID: 20535345 DOI: 10.5056/jnm.2010.16.2.148]
43. Manes G, Menchise A, de Nucci C, Balzano A. Empirical prescribing for dyspepsia: randomised controlled trial of test and treat versus omeprazole treatment. BMJ 2003; 326: 1118 [PMID: 12763982 DOI: 10.1136/bmj.326.7399.1118]
44. Harvey RF, Lane JA, Nair P, Egger M, Harvey I, Donovan J, Murray L. Clinical trial: prolonged beneficial effect of Helicobacter pylori eradication on dyspepsia consultations - the Bristol Helicobacter Project. Aliment Pharmacol Ther 2010; 32: 394-400 [PMID: 20491744 DOI: 10.1111/j.1365-2036.2010.04363.x]
45. Maconi G, Sainaghi M, Molteni M, Bosani M, Gallus S, Ricci G, Alvisi V, Porro GB. Predictors of long-term outcome of functional dyspepsia and duodenal ulcer after successful Helicobacter pylori eradication - a 7-year follow-up study. Eur J Gastroenterol Hepatol 2009; 21: 387-393 [PMID: 19182682 DOI: 10.1097/MEG.0b013e3283069db0]
46. Lassen AT, Hallas J, Schaffalitzky de Muckadell OB. Helicobacter pylori test and eradicate versus prompt endoscopy for management of dyspeptic patients: 6.7 year follow up of a randomised trial. Gut 2004; 53: 1758-1763 [PMID: 15542510 DOI: 10.1136/gut.2004.043570]
47. Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, Lai KC, Hu WH, Yuen ST, Leung SY, Fong DY, Ho J, Ching CK, Chen JS. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004; 291: 187-194 [PMID: 14722144]